Thymosin Alpha-1

What it is

Thymosin Alpha-1 is for the person who gets every cold that goes around, takes three weeks to shake what others shake in five days, or is climbing out of a long illness with an immune system that feels used up. Your thymus makes it naturally and makes less every decade; this puts it back for a few weeks and the immune system settles into working again.

Who actually runs it: people in their forties and up who notice they get sick more often and recover slower than they used to, shift workers and parents of small children in a bad winter, people recovering from a long viral illness or a course of chemo, and people with chronic infections like hepatitis B that the drug is actually approved for abroad. It is also the sensible pick for someone whose immune system is over-reacting as much as under-reacting, because it tunes rather than just pushes. It is not an antibiotic, not a cure for anything acute, and not a stimulant.

What you will notice, and when: very little day to day, which is the point. Some people feel mildly flu-ish, achy or warm in the first two or three days as the immune system wakes up, then it passes. Over four to eight weeks the signal is what does not happen: the office cold skips you, or you get it and it is over in three days. Good at the end of a run looks like a winter with fewer sick days and a faster bounce-back. It will not clear an infection you already have in a week, and it will not make you feel energized.

How people run it: 0.5 mg subQ once a day, same dose the whole way, for a few weeks up to 12. Belly fat, morning or evening, food does not matter. From a 10 mg vial in 1 mL that is 5 units on an insulin syringe and 20 days per vial, so a 12-week run is about four vials. The mistake is running it for five days when you are already sick and expecting a cure; it is a season-long tune-up, not a rescue. The other is ramping the dose, which has no basis; the right move is simply to hold 0.5 mg daily the whole time.

The evidence, once: this is a drug, Zadaxin, approved in more than 30 countries, mainly for hepatitis B, and studied as a vaccine booster in the immune-compromised, with randomized trials in hepatitis, sepsis and as a chemotherapy adjunct. The US never approved it, and the 'fewer colds' use that most people here run it for has no trial behind it; it is extrapolation from the immune-restoring mechanism and a lot of clinic use. So: real human drug, lightly documented casual use, consistently well tolerated.

When it is not worth it: if you are healthy and rarely sick, there is nothing for it to restore. If your problem is a mold or biotoxin illness with the whole cascade of symptoms, VIP within a structured protocol is the targeted tool, not this. If you have an autoimmune disease, the balancing effect is a plausible reason to try it and a real reason to involve the specialist who manages you, because a flare is the thing to watch for. Chonluten is the bioregulator version aimed at lungs and immunity, gentler and less documented.

What people use it for

How it works

Safety, in brief

The full picture — stop signs and who should talk to a doctor first — is on the dosing guide.

Sources

The labels and studies behind this page. Each link opens the original on PubMed, DailyMed or ClinicalTrials.gov.

1. Efficacy of thymosin alpha1 in patients with chronic hepatitis B: a randomized, controlled trialChien et al., Hepatology 1998 · Trial
2. Thymosin-ɑ1 for people with chronic hepatitis BNaing et al., Cochrane Database Syst Rev 2026 · Review
3. Augmentation of influenza antibody response in elderly men by thymosin alpha one. A double-blind placebo-controlled clinical studyGravenstein et al., J Am Geriatr Soc 1989 · Trial
4. The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trialWu et al., BMJ 2025 · Trial